Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
Journal website http://www.jocmr.org |
Original Article
Volume 10, Number 2, February 2018, pages 106-116
Pattern of Thyroid Lesions in Western Region of Saudi Arabia: A Retrospective Analysis and Literature Review
Figures
Tables
Age groups (years) | Male (%) | Female (%) | Total (%) |
---|---|---|---|
Pearson Chi-square = 0.068. | |||
< 20 | 1 (10) | 9 (90) | 10 (5.8) |
21 - 30 | 4 (14.8) | 23 (85.2) | 27 (15.6) |
31 - 40 | 3 (7.5) | 37 (92.5) | 40 (23.1) |
41 - 50 | 6 (12) | 44 (88) | 50 (28.9) |
51 - 60 | 4 (15.4) | 22 (84.6) | 26 (15) |
> 61 | 4 (20) | 16 (80) | 20 (11.6) |
Total | 22 (12.7) | 151 (87.3) | 173 (100) |
Origin of patients | Male (%) | Female (%) | Total | Percent |
---|---|---|---|---|
Saudi | 19 (86.36) | 127 (84.10) | 146 | 84.39 |
Syrian | 0 | 4 (2.66) | 4 | 2.31 |
Palestinian | 0 | 1 (0.66) | 1 | 0.58 |
Egyptian | 0 | 3 (1.99) | 3 | 1.73 |
Pakistani | 3 (13.64) | 6 (3.98) | 9 | 5.2 |
Yemeni | 0 | 5 (3.31) | 5 | 2.89 |
Indonesian | 0 | 1 (0.66) | 1 | 0.58 |
Bangladeshi | 0 | 1 (0.66) | 1 | 0.58 |
Filipino | 0 | 2 (1.32) | 2 | 1.16 |
Myanmar | 0 | 1 (0.66) | 1 | 0.58 |
Total | 22 (100) | 151 (100) | 173 | 100 |
Age groups (years) | Gender | Thyroid lobe | Total (%) | |||||
---|---|---|---|---|---|---|---|---|
Right | Left | Both | Isthmus | Diffuse | LN only | |||
< 20 | Male | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
Female | 3 | 3 | 3 | 0 | 0 | 0 | 9 | |
Total | 4 | 3 | 3 | 0 | 0 | 0 | 10 | |
21 - 30 | Male | 4 | 0 | 0 | 0 | 0 | 0 | 4 |
Female | 14 | 2 | 7 | 0 | 0 | 0 | 23 | |
Total | 18 | 2 | 7 | 0 | 0 | 0 | 27 | |
31 - 40 | Male | 0 | 1 | 2 | 0 | 0 | 0 | 3 |
Female | 15 | 10 | 10 | 1 | 1 | 0 | 37 | |
Total | 15 | 11 | 12 | 1 | 1 | 0 | 40 | |
41 - 50 | Male | 2 | 0 | 4 | 0 | 0 | 0 | 6 |
Female | 16 | 8 | 18 | 1 | 0 | 1 | 44 | |
Total | 18 | 8 | 22 | 1 | 0 | 1 | 50 | |
51 - 60 | Male | 1 | 1 | 2 | 0 | 0 | 0 | 4 |
Female | 7 | 5 | 10 | 0 | 0 | 0 | 22 | |
Total | 8 | 6 | 12 | 0 | 0 | 26 | ||
> 60 | Male | 1 | 0 | 3 | 0 | 0 | 0 | 4 |
Female | 8 | 3 | 5 | 0 | 0 | 0 | 16 | |
Total | 9 | 3 | 8 | 0 | 0 | 0 | 20 | |
Total | 72 (41.6%) | 33 (19.1%) | 64 (37%) | 2 (1.2%) | 1 (0.6%) | 1 (0.6%) | 173 (100%) | |
Pearson Chi-square | 0.505 | 0.792 | 0.491 | 0.806 |
Age groups (years) | Benign nodules (%) | Total (%) | ||||
---|---|---|---|---|---|---|
Not benign | Adenomatous | Colloid | Lymphocytic | Others | ||
< 20 | 0 | 1 | 7 | 2 | 0 | 10 |
21 - 30 | 5 | 2 | 15 | 5 | 0 | 27 |
31 - 40 | 1 | 6 | 30 | 3 | 0 | 40 |
41 - 50 | 5 | 2 | 38 | 5 | 0 | 50 |
51 - 60 | 1 | 3 | 18 | 3 | 1 | 26 |
Total | 14 (8.1) | 16 (9.3) | 124 (71.7) | 18 (10.4) | 1 (0.6) | 173 (100) |
Thyroid lesions | Gender (%) | Total (%) | |
---|---|---|---|
Male | Female | ||
SOM: suspicious of malignancy. | |||
Non-diagnostic | 0 | 4 (2.65) | 4 (2.31) |
Benign | 20 (90.92) | 139 (92.1) | 159 (91.91) |
Atypia | 0 | 1 (0.66) | 1 (0.6) |
SOM | 1 (4.54) | 0 | 1 (0.6) |
Malignant | 1 (4.54) | 7 (4.64) | 8 (4.63) |
Total | 22 (12.72) | 151 (87.28) | 173 (100) |
Adenomatous nodules | 3 (15) | 13 (9.35) | 16 (10.2) |
Colloid nodules | 16 (80) | 108 (77.7) | 124 (77.91) |
Lymphocytic (Hashimoto) | 1 (1) | 17 (12.24) | 18 (11.31) |
Others | 0 | 1 (0.72) | 1 (0.63) |
Total (benign) | 20 (12.58) | 139 (87.42) | 159 (100) |
Age groups (years) | Diagnosis | Gender (%) | Total (%) | |
---|---|---|---|---|
Male | Female | |||
SOM: suspicious of malignancy. | ||||
< 20 | Benign | 1 (100) | 9 (100) | 10 |
Total | 1 (100) | 9 (100) | 10 | |
21 - 30 | Benign | 2 (50) | 20 (86.96) | 22 |
SOM | 1 (25) | 0 | 1 | |
Malignant | 1 (25) | 3 (13.04) | 4 | |
Total | 4 (100) | 23 (100) | 27 | |
31 - 40 | Benign | 3 (100) | 36 (97.3) | 39 |
Malignant | 0 | 1 (2.7) | 1 | |
Total | 3 (100) | 37 | 40 | |
41 - 50 | Non-diagnostic | 0 | 3 (6.82) | 3 |
Benign | 6 (100) | 39 (88.7) | 45 | |
Malignant | 0 | 2 (4.55) | 2 | |
Total | 6 (100) | 44 (100) | 50 | |
51 - 60 | Non-diagnostic | 0 | 1 (4.55) | 1 |
Benign | 4 (100) | 21 (95.45) | 25 | |
Total | 4 (100) | 22 (100) | 26 | |
> 60 | Benign | 4 (100) | 14 | 18 |
Atypia | 0 | 1 | 1 | |
Malignant | 0 | 1 | 1 | |
Total | 4 (20) | 16 (80) | 20 | |
Grand total | 22 (12.72) | 151 (87.28) | 173 (100) |